GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInfra Life Science Inc (XKRX:266470) » Definitions » Common Stock

BioInfra Life Science (XKRX:266470) Common Stock : ₩13,933.0 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioInfra Life Science Common Stock?

BioInfra Life Science's quarterly common stock declined from Dec. 2022 (₩7,053.4 Mil) to Dec. 2023 (₩7,053.4 Mil) but then increased from Dec. 2023 (₩7,053.4 Mil) to Dec. 2024 (₩13,933.0 Mil).

BioInfra Life Science's annual common stock declined from Dec. 2022 (₩7,053.4 Mil) to Dec. 2023 (₩7,053.4 Mil) but then increased from Dec. 2023 (₩7,053.4 Mil) to Dec. 2024 (₩13,933.0 Mil).


BioInfra Life Science Common Stock Historical Data

The historical data trend for BioInfra Life Science's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInfra Life Science Common Stock Chart

BioInfra Life Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only 7,053.42 7,053.42 7,053.42 7,053.42 13,933.01

BioInfra Life Science Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only 7,053.42 7,053.42 7,053.42 7,053.42 13,933.01

BioInfra Life Science Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


BioInfra Life Science Business Description

Traded in Other Exchanges
N/A
Address
Daehak-ro 49, 7th Floor, Jongno-gu, Seoul, KOR, 03127
BioInfra Life Science Inc is a bio-technology company engaged in developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients.

BioInfra Life Science Headlines

No Headlines